ADVERTISEMENT

Comments?
Help us improve Portfolio Grader.


Comments?
Help us improve Portfolio Grader.


Blue Chip Growth

Stock Report: PharMerica Corporation (PMC) Report Updated: Jul 25, 2016 | Print This Page

Get more stock ratings by Louis Navellier

PharMerica Corporation (PMC)

Rating: Sell Volatility: Conservative
Total Grade: D Industry: Health Care Providers & Services
Competitors: DRAD,AHS,CRVL,WOOF

Stock Analysis

Rating: Monthly View

A
B
C
D
F
July August September October November December January February March April May June

Rating: Weekly View

This Week: D down no change
Last Week: D same no change
Two Weeks Ago: D up no change
service keys

PharMerica Corporation© quotemedia

Company Profile

PharMerica Corporation operates as an institutional pharmacy services company in the United States. The company offers services to healthcare facilities; pharmacy management services to hospitals; specialty infusion services to patients outside hospitals; and oncology pharmacy services. It purchases, repackages, and dispenses prescription and non-prescription pharmaceuticals in accordance with physician orders and delivers such medication to healthcare facilities for administration to individual patients and residents. The company also provides hospital pharmacy management services, including hospital pharmacy operations, regulatory and financial management services, and clinical pharmacy programs, as well as offers consultant pharmacist services and medical records services. It operates 98 institutional, 14 specialty infusion, and 5 specialty oncology pharmacies in 45 states, as well as provides pharmacy management services to 89 hospitals in the United States. The company serves institutional healthcare providers, such as skilled nursing facilities, nursing centers, assisted living facilities, hospitals, individuals receiving in-home care, and other long-term alternative care settings. PharMerica Corporation was founded in 2006 and is headquartered in Louisville, Kentucky.